Plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies.

PubWeight™: 1.68‹?› | Rank: Top 3%

🔗 View Article (PMID 17615091)

Published in Am J Epidemiol on July 05, 2007

Authors

Tianying Wu1, Walter C Willett, Nader Rifai, Eric B Rimm

Author Affiliations

1: Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA. hptwu@channing.harvard.edu

Articles citing this

Optimal hemodialysis vascular access in the elderly patient. Semin Dial (2012) 1.05

Oxidative balance score, colorectal adenoma, and markers of oxidative stress and inflammation. Cancer Epidemiol Biomarkers Prev (2014) 0.95

Fluorescent oxidation products and risk of coronary heart disease: a prospective study in women. J Am Heart Assoc (2013) 0.94

Plasma florescent oxidation products and breast cancer risk: repeated measures in the Nurses' Health Study. Breast Cancer Res Treat (2013) 0.89

Dietary Weight Loss, Exercise, and Oxidative Stress in Postmenopausal Women: A Randomized Controlled Trial. Cancer Prev Res (Phila) (2016) 0.88

Oxidative balance score and oxidative stress biomarkers in a study of Whites, African Americans, and African immigrants. Biomarkers (2014) 0.83

Impact of Oxidative Stress Biomarkers and Carboxymethyllysine (an Advanced Glycation End Product) on Prostate Cancer: A Prospective Study. Clin Genitourin Cancer (2015) 0.81

Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses' health studies. Breast Cancer Res Treat (2015) 0.81

Re: "plasma fluorescent oxidation products as potential markers of oxidative stress for epidemiologic studies". Am J Epidemiol (2008) 0.77

Association between global biomarkers of oxidative stress and hip fracture in postmenopausal women: a prospective study. J Bone Miner Res (2014) 0.76

Influence of cataract maturity on aqueous humor lipid peroxidation markers and antioxidant enzymes. Eye (Lond) (2013) 0.75

Plasma fluorescent oxidation products and risk of estrogen receptor-negative breast cancer in the Nurses' Health Study and Nurses' Health Study II. Breast Cancer Res Treat (2016) 0.75

Phobic Anxiety and Plasma Levels of Global Oxidative Stress in Women. Eur J Psychiatry (2015) 0.75

Association between plasma fluorescent oxidation products and erectile dysfunction: A prospective study. BMC Urol (2015) 0.75

Healthy Dietary Patterns and Oxidative Stress as Measured by Fluorescent Oxidation Products in Nurses' Health Study. Nutrients (2016) 0.75

Plasma fluorescent oxidation products and short-term occupational particulate exposures. Am J Ind Med (2012) 0.75

Articles by these authors

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation (2003) 23.97

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet (2007) 22.96

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet (2007) 21.18

Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet (2008) 17.65

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23

Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60

Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA (2007) 15.32

Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34

Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med (2011) 12.29

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr (2006) 10.95

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05

Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA (2007) 9.68

C-reactive protein levels and outcomes after statin therapy. N Engl J Med (2005) 9.47

Fruit and vegetable intake and risk of major chronic disease. J Natl Cancer Inst (2004) 8.77

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care (2010) 8.52

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med (2008) 8.03

Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA (2006) 7.73

Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med (2013) 7.72

The public health and economic benefits of taxing sugar-sweetened beverages. N Engl J Med (2009) 7.48

Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46

Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1·8 million participants. Lancet (2013) 7.34

C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation (2008) 7.33

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Optimal diets for prevention of coronary heart disease. JAMA (2002) 7.24

Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst (2006) 7.19

C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation (2003) 6.99

Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension (2007) 6.99

Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance. Am J Clin Nutr (2002) 6.96

Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87

A pooled analysis of vitamin D dose requirements for fracture prevention. N Engl J Med (2012) 6.85

Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr (2005) 6.67

Trans fatty acids and cardiovascular disease. N Engl J Med (2006) 6.67

Effect of Vitamin D on falls: a meta-analysis. JAMA (2004) 6.64

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62

Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51

Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16

Effect of sleep loss on C-reactive protein, an inflammatory marker of cardiovascular risk. J Am Coll Cardiol (2004) 6.08

Sugar-sweetened beverages and genetic risk of obesity. N Engl J Med (2012) 5.98

Hemoglobin A1c predicts diabetes but not cardiovascular disease in nondiabetic women. Am J Med (2007) 5.95

Roles of drinking pattern and type of alcohol consumed in coronary heart disease in men. N Engl J Med (2003) 5.95

Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA (2005) 5.95

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr (2009) 5.79

C-reactive protein and the risk of developing hypertension. JAMA (2003) 5.75

Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA (2005) 5.74

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern Med (2009) 5.63

Alternative dietary indices both strongly predict risk of chronic disease. J Nutr (2012) 5.60

Dairy consumption and risk of type 2 diabetes mellitus in men: a prospective study. Arch Intern Med (2005) 5.59

C-reactive protein and the risk of incident colorectal cancer. JAMA (2004) 4.94

Serum aldosterone and the incidence of hypertension in nonhypertensive persons. N Engl J Med (2004) 4.92

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Exercise type and intensity in relation to coronary heart disease in men. JAMA (2002) 4.69

Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes (2004) 4.67

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care (2006) 4.62

Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation (2004) 4.58

Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care (2002) 4.48

Habitual caffeine intake and the risk of hypertension in women. JAMA (2005) 4.46

Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med (2003) 4.40

The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr (2007) 4.36

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr (2004) 4.29

Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med (2004) 4.27

Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA (2011) 4.25

Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men. Circulation (2012) 4.24

Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med (2002) 4.21

Dietary patterns and risk for type 2 diabetes mellitus in U.S. men. Ann Intern Med (2002) 4.19

Association between C-reactive protein and age-related macular degeneration. JAMA (2004) 4.16

Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med (2006) 4.16

A new proposed guidance system for beverage consumption in the United States. Am J Clin Nutr (2006) 4.12

Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol (2007) 4.11

A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology (2013) 4.06

Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA (2004) 4.04

Comparison of risk factors for colon and rectal cancer. Int J Cancer (2004) 4.03

High school dietary dairy intake and teenage acne. J Am Acad Dermatol (2005) 4.00

Statin drugs and risk of advanced prostate cancer. J Natl Cancer Inst (2006) 3.96

Association of nut consumption with total and cause-specific mortality. N Engl J Med (2013) 3.94

Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation (2009) 3.93

Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr (2009) 3.90

Estimating the number of deaths due to obesity: can the divergent findings be reconciled? J Womens Health (Larchmt) (2007) 3.86

Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation (2005) 3.85